Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Biologics - Large Molecule
Sort By
Newest First
1 / 29
1 / 29
QbD
Designing Quality into Biomanufacturing
Miguel Carrion; Michelle Kneeland
Tanvex CDMO
PAO-10-24-CL-09
Oct 29, 2024
Fill/Finish
Superior Performance of SaniSure® Pharm-A-Clear LH® Tubing in Extended Fill/Finish Applications
Alex Van Hagen, Ph.D.; Nicholas Brust
Sanisure
PAO-08-24-CL-10
Oct 29, 2024
Advanced Therapies
A New Vision for Progressing Advanced Therapies
Nathaniel Youndt
ReciBioPharm
PAO-10-24-CL-13
Oct 25, 2024
Large Molecule
Waters New Bioseparations Tools Accelerate and Improve Development of RNA-based Vaccines and Therapies Using LC-MS Analysis
Waters Corporation
PR-10-24-NI-38
Oct 11, 2024
CDMO
Innovating and Collaborating to Support Biopharma Beyond the Typical CDMO
Janet Hoogstraate, Ph.D.
NorthX Biologics
PAO-10-24-CL-07
Oct 07, 2024
Financing
Halozyme Announces Expansion of Global Collaboration and License Agreement with argenx for ENHANZE
Halozyme Therapeutics
PR-09-24-NI-31
Oct 04, 2024
RNA
Optimized Residual dsRNA Detection for mRNA Therapeutics
Eunseo (Ency) Lee, Ph.D; Namhyun Kim; Hwanjun Yoon, Ph.D.; Sukhwan Kim; Ahyeon Hwang
Samsung Biologics
PAO-09-24-CL-07
Sep 30, 2024
Bioassays
Developing a Toolbox of Functional Bioassays for Optimizing ADCC
Anke Hartung, Ph.D.,
Tanvex CDMO
PAO-09-24-CL-09
Sep 30, 2024
Process Development
Economic Benefits of Digital Process Development
Fabian Feidl, Ph.D.
DataHow
PAO-10-24-CL-02
Sep 24, 2024
Expansion
Building on a Pioneering Biomanufacturing Legacy with Client Centricity
Benedikt von Braunmühl; Tom Roberts
Rentschler Biopharma SE
PAO-09-24-CL-05
Sep 09, 2024
Biosimilars
Tanvex Appoints Biopharma Industry Veteran Stephen Lam as CEO
Tanvex Biopharma
PR-09-24-NI-02
Sep 05, 2024
Developability
Mitigating Early Development Risks with Samsung Biologics DEVELOPICK™ Platform
Heonchang Lim
Samsung Biologics
PAO-09-24-CL-04
Sep 04, 2024
Comparability
Leveraging Risk Assessment for Demonstrating Product Comparability after Manufacturing Process Changes
Pawel Stanczak, Ph.D.; Xuemei Han, Ph.D.; Miguel Carrion
Tanvex CDMO
PAO-07-24-CL-08
Aug 26, 2024
Digitalization
Radical Bioprocessing Efficiencies and Cost Reductions — The Next Wave of Biopharmaceutical Innovation
Michael Sokolov, Ph.D.
DataHow
PAO-08-24-CL-02
Aug 26, 2024
Sequence Variants
Accelerating Protein Sequence Variant Analysis
Kyoungmin Lee; Yunjeong Heo; Jongbae Park
Samsung Biologics
PAO-08-24-CL-08
Aug 13, 2024
Global Access
How Can (Bio)pharmaceutical Companies Contribute to Improving Global Access to Essential Medications?
Pharma's Almanac
PAO-08-24-RT-02
Aug 07, 2024
Biosimilars
Biosimilars: Manufacturing and Supply Chain for Worldwide Patients
Paula Olcese
Biosidus
PAO-08-24-CL-06
Aug 07, 2024
Developability
Streamlining the Path to Approval with Developability and Pre-Formulation Platforms
Andrea Hawe
Coriolis Pharma
PAO-07-24-CL-11
Aug 01, 2024
CDMO Model
Rethinking the Conventional CDMO Model
Wheeler Bio
PAO-08-24-CL-04
Jul 29, 2024
Regulatory
Building a Path to Approval with Effective Regulatory Support
Mira Han
Samsung Biologics
PAO-07-24-CL-12
Jul 29, 2024